Hsa-Mir-1 and Hsa-Mir-1229 expression levels in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control groups

Hsa-Mir-1 and Hsa-Mir-1229 expression levels in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control groups

Background. Recurrent pregnancy loss is defined as at least two consecutive clinical pregnancy losses before 20th week of gestation. In this study, we investigated microRNA-1 and microRNA-1229 in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control group. Meth...

Full description

Bibliographic Details
Main Authors: Mortaza Raeisi, Mehdi Yousefi, Javad Ahmadian Haris, Shahla Danaii, Mohammad Tofighifard, Pouya Bahlouli, leili Aghebati-Maleki
Format: Article
Language:fas
Published: Tabriz University of Medical Sciences 2024-04-01
Series:مجله پزشکی دانشگاه علوم پزشکی تبریز
Subjects:
lymphocyte therapy
microrna
inflammation
recurrent pregnancy loss
Online Access:https://mj.tbzmed.ac.ir/PDF/mj-46-19.pdf

Internet

https://mj.tbzmed.ac.ir/PDF/mj-46-19.pdf

Similar Items